Venmax Drugs Board Meeting on Aug 31 to Approve Annual Report

Venmax Drugs and Pharmaceuticals Ltd has announced a Board of Directors meeting scheduled for August 31, 2026. The meeting will primarily focus on approving the 37th Annual Report, including the Directors' Report and Notice of the Annual General Meeting for the Financial Year 2025-26. Key agenda items also include deciding the date, time, and venue for the AGM, fixing cut-off dates for e-voting, and approving the appointment of a scrutinizer and e-voting agency. The board will also consider the regularization of additional directors and changes in the designation of a whole-time director, subject to shareholder approval.